PharmacokineticsAbsorption:Thehalf-lifeofFRAGMINhasbeenshowntobe2hoursafterintravenousinjectionand3-4hoursaftersubcutaneousinjection.Thebioavailabilityaftersubcutaneousinjectionisapproximately90%andth
ACTIONANDCLINICALPHARMACOLOGYMechanismofActionFRAGMINisalowmolecularweightheparinwithantithromboticproperties.Dalteparinsodiumisproducedthroughcontrollednitrousaciddepolymerizationofsodiumheparinfromp
Enoxaparinisusedtopreventandtreatharmfulbloodclots.Thishelpstoreducetheriskofastrokeorheartattack.Thismedicationhelpskeepyourbloodflowingsmoothlybyloweringtheactivityofclottingproteinsintheblood.Enoxa
Dalteparinisananticoagulantthathelpspreventtheformationofbloodclots.Dalteparinisusedtogetherwithaspirintopreventbloodvesselcomplicationsinpeoplewithcertaintypesofangina(chestpain)orheartattack.Daltepa